Design of Clinical Trials of Antidepressants: Should a Placebo Control Arm be Included?

Author： Fritze J.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.15, Iss.10, 2001-01, pp. : 755-764

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Social Functioning: Should it Become an Endpoint in Trials of Antidepressants?

By Bech Per  

CNS Drugs, Vol. 19, Iss. 4, 2005-01 ,pp. : 313-324

Adis International

Access to resources Recommend Favorite

Are clinical trials worth it to insurers?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 348, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Unrelated Medical Costs in Life-Years Gained: Should They be Included in Economic Evaluations of Healthcare Interventions?

By Rappange David R.  

PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. : 815-830

Adis International

Access to resources Recommend Favorite

Studies of Long-Term Use of Antidepressants: How Should the Data from Them be Interpreted?

By El-Mallakh Rif S.   Briscoe Brian  

CNS Drugs, Vol. 26, Iss. 2, 2012-02 ,pp. : 97-109

Adis International

Access to resources Recommend Favorite

Clinical trials agreement in the UK: to good to be true?

By  

Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite